A new longevity stem cell therapy in monkeys showed an estimated 3–5 yrs of biological age

Well SupportedTranscriptomic and epigenetic analyses confirmed biological age reversal in organs like skin, aorta, lungs, and the digestive system following stem cell therapy.

Well SupportedSenescence resistant mesenchymal progenitor cells (SRCs) engineered with the longevity gene FOXO3 can halt and partially reverse aging in aged macaques.

Partially SupportedStem cell therapy with SRCs restored cortical thickness and volume toward youthful levels in monkeys, showing up to 50-70% improvement compared to 10-20% with WTCs.

Partially SupportedStem cell therapy administered at a dose of 2 million cells/kg intravenously biweekly for 44 weeks showed no adverse safety events.